APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ranitidine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ranitidine Market Outlook and Growth Opportunities 2026

20 December 2025196 pages

Choose your research edition.

Industry ResearchRanitidine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Ranitidine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Ranitidine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ranitidine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ranitidine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Ranitidine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ranitidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ranitidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ranitidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ranitidine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ranitidine market include GSK, Sun Pharma, Merck, Tocris Bioscience (R & D Systems), Strides Pharma Science Limited (Strides Shasun) and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ranitidine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ranitidine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ranitidine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ranitidine market size, projected growth trends, production technologies, key applications, and end-use industries.

Ranitidine Segment by Company

GSK

Sun Pharma

Merck

Tocris Bioscience (R & D Systems)

Strides Pharma Science Limited (Strides Shasun)

Boehringer Ingelheim

Ranitidine Segment by Type

Tablet

Syrup

Injection

Ranitidine Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Ranitidine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Ranitidine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ranitidine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ranitidine significant trends, drivers, influence factors in global and regions.

6. To analyze Ranitidine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ranitidine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ranitidine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ranitidine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ranitidine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ranitidine industry.

Chapter 3: Detailed analysis of Ranitidine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ranitidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ranitidine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ranitidine Industry Trends Table 2. Ranitidine Industry Drivers Table 3. Ranitidine Industry Opportunities and Challenges Table 4. Ranitidine Industry Restraints Table 5. Global Ranitidine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ranitidine Revenue Share by Company (2021-2026) Table 7. Global Ranitidine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ranitidine Sales Volume Share by Company (2021-2026) Table 9. Global Ranitidine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Ranitidine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ranitidine Key Company Manufacturing Base & Headquarters Table 12. Global Ranitidine Company, Product Type & Application Table 13. Global Ranitidine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ranitidine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Syrup Table 19. Significant Companies of Injection Table 20. Global Ranitidine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Ranitidine Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Ranitidine Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Ranitidine Sales Volume Share by Type (2021-2026) Table 24. Global Ranitidine Sales Volume Share by Type (2027-2032) Table 25. Global Ranitidine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ranitidine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Ranitidine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Ranitidine Sales Value Share by Type (2021-2026) Table 29. Global Ranitidine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Online Pharmacies Table 32. Significant Companies of Hospital Pharmacies Table 33. Global Ranitidine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Ranitidine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Ranitidine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Ranitidine Sales Volume Share by Application (2021-2026) Table 37. Global Ranitidine Sales Volume Share by Application (2027-2032) Table 38. Global Ranitidine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Ranitidine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Ranitidine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Ranitidine Sales Value Share by Application (2021-2026) Table 42. Global Ranitidine Sales Value Share by Application (2027-2032) Table 43. Global Ranitidine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Ranitidine Sales by Region (2021-2026) & (K Units) Table 45. Global Ranitidine Sales Market Share by Region (2021-2026) Table 46. Global Ranitidine Sales by Region (2027-2032) & (K Units) Table 47. Global Ranitidine Sales Market Share by Region (2027-2032) Table 48. Global Ranitidine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Ranitidine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Ranitidine Sales Value Share by Region (2021-2026) Table 51. Global Ranitidine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Ranitidine Sales Value Share by Region (2027-2032) Table 53. Global Ranitidine Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Ranitidine Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Ranitidine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Ranitidine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Ranitidine Sales by Country (2021-2026) & (K Units) Table 58. Global Ranitidine Sales Market Share by Country (2021-2026) Table 59. Global Ranitidine Sales by Country (2027-2032) & (K Units) Table 60. Global Ranitidine Sales Market Share by Country (2027-2032) Table 61. Global Ranitidine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Ranitidine Sales Value Market Share by Country (2021-2026) Table 63. Global Ranitidine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Ranitidine Sales Value Market Share by Country (2027-2032) Table 65. GSK Company Information Table 66. GSK Business Overview Table 67. GSK Ranitidine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. GSK Ranitidine Product Portfolio Table 69. GSK Recent Development Table 70. Sun Pharma Company Information Table 71. Sun Pharma Business Overview Table 72. Sun Pharma Ranitidine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Sun Pharma Ranitidine Product Portfolio Table 74. Sun Pharma Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck Ranitidine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Merck Ranitidine Product Portfolio Table 79. Merck Recent Development Table 80. Tocris Bioscience (R & D Systems) Company Information Table 81. Tocris Bioscience (R & D Systems) Business Overview Table 82. Tocris Bioscience (R & D Systems) Ranitidine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Tocris Bioscience (R & D Systems) Ranitidine Product Portfolio Table 84. Tocris Bioscience (R & D Systems) Recent Development Table 85. Strides Pharma Science Limited (Strides Shasun) Company Information Table 86. Strides Pharma Science Limited (Strides Shasun) Business Overview Table 87. Strides Pharma Science Limited (Strides Shasun) Ranitidine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Strides Pharma Science Limited (Strides Shasun) Ranitidine Product Portfolio Table 89. Strides Pharma Science Limited (Strides Shasun) Recent Development Table 90. Boehringer Ingelheim Company Information Table 91. Boehringer Ingelheim Business Overview Table 92. Boehringer Ingelheim Ranitidine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Boehringer Ingelheim Ranitidine Product Portfolio Table 94. Boehringer Ingelheim Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Ranitidine Distributors List Table 98. Ranitidine Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Ranitidine Product Image Figure 2. Global Ranitidine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ranitidine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ranitidine Sales (2021-2032) & (K Units) Figure 5. Global Ranitidine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Ranitidine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Syrup Image Figure 11. Injection Image Figure 12. Global Ranitidine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Ranitidine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Ranitidine Sales Volume Share by Type (2021-2032) Figure 15. Global Ranitidine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ranitidine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Ranitidine Sales Value Share by Type (2021-2032) Figure 18. Retail Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Hospital Pharmacies Image Figure 21. Global Ranitidine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Ranitidine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Ranitidine Sales Volume Share by Application (2021-2032) Figure 24. Global Ranitidine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Ranitidine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Ranitidine Sales Value Share by Application (2021-2032) Figure 27. Global Ranitidine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Ranitidine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Ranitidine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Ranitidine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Ranitidine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Ranitidine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Ranitidine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Ranitidine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Ranitidine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Ranitidine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Ranitidine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Ranitidine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Ranitidine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Ranitidine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Ranitidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Ranitidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Ranitidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Ranitidine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Ranitidine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Syrup
  • Injection
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • GSK
  • Sun Pharma
  • Merck
  • Tocris Bioscience (R & D Systems)
  • Strides Pharma Science Limited (Strides Shasun)
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ranitidine Sales Value (2021-2032)
  4. 1.2.2 Global Ranitidine Sales Volume (2021-2032)
  5. 1.2.3 Global Ranitidine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ranitidine Market Dynamics
  1. 2.1 Ranitidine Industry Trends
  2. 2.2 Ranitidine Industry Drivers
  3. 2.3 Ranitidine Industry Opportunities and Challenges
  4. 2.4 Ranitidine Industry Restraints
3 Ranitidine Market by Company
  1. 3.1 Global Ranitidine Company Revenue Ranking in 2025
  2. 3.2 Global Ranitidine Revenue by Company (2021-2026)
  3. 3.3 Global Ranitidine Sales Volume by Company (2021-2026)
  4. 3.4 Global Ranitidine Average Price by Company (2021-2026)
  5. 3.5 Global Ranitidine Company Ranking (2024-2026)
  6. 3.6 Global Ranitidine Company Manufacturing Base and Headquarters
  7. 3.7 Global Ranitidine Company Product Type and Application
  8. 3.8 Global Ranitidine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ranitidine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ranitidine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ranitidine Market by Type
  1. 4.1 Ranitidine Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Syrup
  4. 4.1.3 Injection
  5. 4.2 Global Ranitidine Sales Volume by Type
  6. 4.2.1 Global Ranitidine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ranitidine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Ranitidine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Ranitidine Sales Value by Type
  10. 4.3.1 Global Ranitidine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Ranitidine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Ranitidine Sales Value Share by Type (2021-2032)
5 Ranitidine Market by Application
  1. 5.1 Ranitidine Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Ranitidine Sales Volume by Application
  6. 5.2.1 Global Ranitidine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ranitidine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ranitidine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ranitidine Sales Value by Application
  10. 5.3.1 Global Ranitidine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ranitidine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ranitidine Sales Value Share by Application (2021-2032)
6 Ranitidine Regional Sales and Value Analysis
  1. 6.1 Global Ranitidine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ranitidine Sales by Region (2021-2032)
  3. 6.2.1 Global Ranitidine Sales by Region: 2021-2026
  4. 6.2.2 Global Ranitidine Sales by Region (2027-2032)
  5. 6.3 Global Ranitidine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ranitidine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ranitidine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ranitidine Sales Value by Region (2027-2032)
  9. 6.5 Global Ranitidine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ranitidine Sales Value (2021-2032)
  12. 6.6.2 North America Ranitidine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ranitidine Sales Value (2021-2032)
  15. 6.7.2 Europe Ranitidine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ranitidine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ranitidine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ranitidine Sales Value (2021-2032)
  21. 6.9.2 South America Ranitidine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ranitidine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ranitidine Sales Value Share by Country, 2025 VS 2032
7 Ranitidine Country-level Sales and Value Analysis
  1. 7.1 Global Ranitidine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ranitidine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ranitidine Sales by Country (2021-2032)
  4. 7.3.1 Global Ranitidine Sales by Country (2021-2026)
  5. 7.3.2 Global Ranitidine Sales by Country (2027-2032)
  6. 7.4 Global Ranitidine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ranitidine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ranitidine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ranitidine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ranitidine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ranitidine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ranitidine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ranitidine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ranitidine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ranitidine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ranitidine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ranitidine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ranitidine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ranitidine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ranitidine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ranitidine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ranitidine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ranitidine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ranitidine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ranitidine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ranitidine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ranitidine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ranitidine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ranitidine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ranitidine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ranitidine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ranitidine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ranitidine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ranitidine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ranitidine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ranitidine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ranitidine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ranitidine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ranitidine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ranitidine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ranitidine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ranitidine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ranitidine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ranitidine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ranitidine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ranitidine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ranitidine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ranitidine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ranitidine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ranitidine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ranitidine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ranitidine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ranitidine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ranitidine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ranitidine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ranitidine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ranitidine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ranitidine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ranitidine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ranitidine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ranitidine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ranitidine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ranitidine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ranitidine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ranitidine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ranitidine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ranitidine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ranitidine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ranitidine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ranitidine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ranitidine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ranitidine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ranitidine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ranitidine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ranitidine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ranitidine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ranitidine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ranitidine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ranitidine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ranitidine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ranitidine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ranitidine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ranitidine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ranitidine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ranitidine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ranitidine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ranitidine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ranitidine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ranitidine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ranitidine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ranitidine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ranitidine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Ranitidine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Ranitidine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Sun Pharma
  8. 8.2.1 Sun Pharma Company Information
  9. 8.2.2 Sun Pharma Business Overview
  10. 8.2.3 Sun Pharma Ranitidine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharma Ranitidine Product Portfolio
  12. 8.2.5 Sun Pharma Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Ranitidine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Ranitidine Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Tocris Bioscience (R & D Systems)
  20. 8.4.1 Tocris Bioscience (R & D Systems) Company Information
  21. 8.4.2 Tocris Bioscience (R & D Systems) Business Overview
  22. 8.4.3 Tocris Bioscience (R & D Systems) Ranitidine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tocris Bioscience (R & D Systems) Ranitidine Product Portfolio
  24. 8.4.5 Tocris Bioscience (R & D Systems) Recent Developments
  25. 8.5 Strides Pharma Science Limited (Strides Shasun)
  26. 8.5.1 Strides Pharma Science Limited (Strides Shasun) Company Information
  27. 8.5.2 Strides Pharma Science Limited (Strides Shasun) Business Overview
  28. 8.5.3 Strides Pharma Science Limited (Strides Shasun) Ranitidine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Strides Pharma Science Limited (Strides Shasun) Ranitidine Product Portfolio
  30. 8.5.5 Strides Pharma Science Limited (Strides Shasun) Recent Developments
  31. 8.6 Boehringer Ingelheim
  32. 8.6.1 Boehringer Ingelheim Company Information
  33. 8.6.2 Boehringer Ingelheim Business Overview
  34. 8.6.3 Boehringer Ingelheim Ranitidine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Boehringer Ingelheim Ranitidine Product Portfolio
  36. 8.6.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ranitidine Value Chain Analysis
  2. 9.1.1 Ranitidine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ranitidine Sales Mode & Process
  6. 9.2 Ranitidine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ranitidine Distributors
  9. 9.2.3 Ranitidine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst